State-of-the-art of multidisciplinary approach of bone metastasis-directed therapy: review and challenging questions for preparation of a GEMO practice guidelines.

Fiche publication

Date publication

avril 2025

Journal

Cancer metastasis reviews

Auteurs

Membres identifiés du Cancéropôle Est :
Dr FAIVRE Jean-Christophe , Dr MARTZ Nicolas

Tous les auteurs :
Mesny E, Martz N, Stacoffe N, Clarençon F, Louis M, Mansouri N, Sirveaux F, Thureau S, Faivre JC

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40220136

Résumé

Bone is a common secondary site of dissemination during the course of cancer. Bone metastases (BM) can be associated with skeletal-related events (SRE) such as disabling pain, hypercalcemia, and bone instability that leads to pathological fractures or spinal cord compression. SRE contribute to high morbidity as well as, mortality, and have a negative economic impact. Modern management of BM integrates focal treatments (such as radiotherapy, surgery, and interventional radiology), orthoses, and antiresorptive and systemic oncological treatment. The choice of a metastasis-directed therapy depends on the objective of the treatment, the patient characteristics, and the complete assessment of the bone lesion (pain, neurological risk, and instability). In the narrative review present herein, we aim to provide an updated summary of the literature, with description of the advantages and disadvantages of current and emerging strategies in the multimodal treatment of BM and, based on these data, an updated algorithm for the management of BM.